LumiraDx shares these and other findings from its second annual U.S. survey “Point of Care Diagnostics: A Clinician's View” WALTHAM, Mass., Dec. 08, 2022 (GLOBE NEWSWIRE) -- LumiraDx Limited (Nasdaq: ...

Point-of-care testing (POCT) for sexually transmitted infections offers rapid, decentralised diagnostics that inform clinical decisions within a single visit. Traditionally, laboratory-based nucleic ...

The company’s focus on high accuracy POCT testing reagents aligns precisely with this demand, integrating robust quality control, innovative biochemistry, and user-centered design. Moreover, the ...

QuidelOrtho (QDEL) is looking to sell its point-of-care testing unit at a $1.5B valuation, and private equity groups have already expressed interest in the transaction, The Financial Times reported on ...

After the COVID-19 pandemic, fever clinics urgently require rapid nucleic acid tests to enhance their capacity for timely pathogen detection. This study evaluated the ...

Diagnostics firm QuidelOrtho Corp is looking to sell its point-of-care testing unit at a valuation of $1.5 billion, the ...

Point-of-care-testing for suspected COVID-19 reduces time to results and may improve infection control, suggesting these tests might have clinical advantages over widely used laboratory PCR methods.

Large scale deployment of rapid, low-cost, hand-held point of care testing devices for diagnosing infectious diseases is critical for improving global health. Recent advances in engineering and ...

DUBLIN, Dec. 15, 2020 /PRNewswire/ -- The "Global Point-of-Care Testing Market, by Product (Glucometers, BGE Analyzers, Pregnancy Tests, Infectious Diseases), Outlook 2022" report has been added to ...

NINGBO, ZHEJIANG, CHINA, February 3, 2026 /EINPresswire.com/ — Ningbo Qinmeng Maternal and Child Products Co., Ltd., a subsidiary of Ningbo Ciliang Import and ...